(PharmaNewsWire.Com, April 24, 2018 ) The Latin America Genome Editing Market was worth USD 0.31 billion in 2016 and estimated to be growing at a CAGR of 14.92%, to reach USD 0.62 billion by 2021. Genome editing is the deliberate alteration of a selected DNA sequence in a living cell. It involves cutting a strand of DNA at a specific point and naturally existing cellular repair mechanisms are counted on to fix the broken strands. The repair process can be altered so as to make desired changes in the DNA sequence. Genome Editing can be categorized based on whether they result in the loss of function or gain of function.
Genome Editing has found the most uses in scientific research, for instance in the investigation of human diseases using scientific models. The potential applications of this are much wider than just research. Given that genome editing has the potential to be used in the editing of DNA of any organism, be it bacteria, plants, animals or human beings, the range of possibilities is limitless. Some areas of application worth mentioning include crops and livestock, industrial biotechnology, biomedicine and reproduction.
The key drivers of the Genome Editing Market in Latin America include increased R&D expenditure, growth of biotechnology and pharmaceutical industries and increasing public and private sector funding into the development of the sector. Other factors such as rapid advancements in sequencing and gene-editing technologies, non-labelling of gene-edited products such as Genetically Modified Organisms and various applications in drug discovery. Inspite of the drivers, factors such as the stringent regulatory framework and ethical concerns regarding the edition of human embryo are hampering the market growth. Unavailability of gene-editing based therapeutics in the market and patent disputes are other noteworthy constraints.
The Latin America Genome Editing market is broadly classified into Cell Line, Animal Genetic and Plant Genetic Engineering in the basis of application, by technology into CRISPR, TALEN, ZFN, Antisense and Other Technologies and on the basis of end user into Biotechnological & Pharmaceutical Companies, Academic and Government Research Institutes and Contract Research Organizations. Based on geography, the Latin America market is divided into Argentina, Brazil, Mexico and rest of Latin American nations. The market is one that promises huge promise in the coming years due to the emerging markets in the region. At present, it forms just a small part of the global market share with only Middle-East & Africa generating less revenue than the region. Inspite of the small size, it has the second highest growth rate globally.
The Genome Editing market is highly competitive with a large number of players. Some of the major ones are Thermo Fisher Scientific, Merck KGAA, Horizon Discovery Group Plc, Genscript Biotech Corporation, Sangamo Biosciences, Integrated DNA Technologies, Lonza Group Ltd, New England Biolabs, Origene Technologies, and Transposagen Biopharmaceuticals.
The scope of the report provides: The evaluation of the current market for your product or services and the future implications of the market Addresses the opportunities by better understanding the market through size estimates and growth rate analysis to forecast the market for the future Extensive segmentation to understand the dynamics of market at a very granular level by splitting down the market to the smallest segment Addresses the key market dynamics involving the drivers, restraints and challenges with an aim of providing insights for gaining market share The factors responsible for the shaping of the industry as it is as a result of competitive environment is analyzed through Porters Five Forces The effects of political, economic, social, technological, legal and environmental factors on the industry is analyzed through PESTLE analysis to better understand the aspects of strategic management required to comply with the exogenous and endogenous factors Strategic evaluation of the key players to gain insights of their performance allowing access to their product portfolio, financial performance and the strengths of their business strategic developments Comparative study of the firms across the industry measuring their performances based on market share and recent activities in order to achieve competitive intelligence Equip you with the information providing with the investment opportunities in the industry
Looking for more? If you are in need of a specific research study, we have an expertise in undertaking a customized study and will aid to meet your research requirement to the fullest.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
